MRI features and prognostic evaluation in patients with subventricular zone-contacting IDH-wild-type glioblastoma
, , , und
30. Mai 2025
Über diesen Artikel
Artikel-Kategorie: research article
Online veröffentlicht: 30. Mai 2025
Eingereicht: 06. Jan. 2025
Akzeptiert: 27. März 2025
DOI: https://doi.org/10.2478/raon-2025-0029
Schlüsselwörter
© 2025 Shijiao Pan et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1.

FIGURE 2.

Figure 3.

FIGURE 4.

Univariate and multivariate Cox regression analyses for overall survival in glioblastoma patients
Parameter | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.025 | 1.015–1.036 | < 0.001 |
1.024 | 1.014–1.034 | < 0.001 |
Gender | 1.009 | 0.817–1.247 | 0.933 | |||
Tumor size | 1.112 | 1.039–1.190 | 0.002 |
1.053 | 0.966–1.148 | 0.239 |
Peritumoral edema | 0.950 | 0.876–1.029 | 0.207 | |||
Tumor shape | 0.783 | 0.513–1.195 | 0.257 | |||
Enhancement type | 0.687 | 0.475–0.993 | 0.046 |
0.771 | 0.532–1.117 | 0.170 |
Enhancement degree | 1.004 | 0.732–1.377 | 0.980 | |||
Cystic lesion | 0.904 | 0.722–1.133 | 0.383 | |||
Necrosis | 1.008 | 0.519–1.956 | 0.982 | |||
Multifocal lesions | 1.635 | 1.201–2.225 | 0.002 |
1.548 | 1.111–2.158 | 0.010 |
Crossing the midline | 1.763 | 1.196–2.599 | 0.004 |
1.415 | 0.936–2.138 | 0.099 |
SVZ contact | 1.650 | 1.326–2.052 | < 0.001 |
1.364 | 1.037–1.794 | 0.027 |
Comparison of clinical and MRI characteristics between the subventricular zone contact and non-contact groups
Characteristic | SVZ Contact (n = 239) | SVZ Non-contact (n = 132) | p value |
---|---|---|---|
Age (year) | 65 ± 11 | 63 ± 10 | 0.085 |
Gender, n (%) | 0.237 | ||
Male | 149 (62.3) | 74 (56.1) | |
Female | 90 (37.7) | 58 (43.9) | |
OS (month) | 11.0 (5.0–18.0) | 17.5 (12.0–28.5) | < 0.001 |
Tumor size (cm) | 5.07 ± 1.35 | 3.31 ± 1.12 | < 0.001 |
Peritumoral edema (cm) | 1.83 (1.02–2.70) | 1.70 (0.55–2.62) | 0.192 |
Tumor shape/n (%) | 0.016 |
||
Regularity | 10 (4.2) | 14 (10.6) | |
Irregularity | 229 (95.8) | 118 (89.4) | |
Enhancement type/n (%) | 0.030 |
||
Ring | 15 (6.2) | 17 (12.9) | |
Non-ring | 224 (93.8) | 115 (87.1) | |
Enhancement degree/n (%) | 0.386 | ||
Significant | 212 (88.7) | 113 (85.6) | |
Non-significant | 27 (11.3) | 19 (14.4) | |
Cystic lesion/n (%) | 0.004 |
||
Yes | 83 (34.7) | 27 (20.5) | |
No | 156 (65.3) | 105 (79.5) | |
Necrosis/n (%) | 0.011 |
||
Yes | 237 (99.2) | 125 (94.7) | |
No | 2 (0.8) | 7 (5.3) | |
Multifocal lesions (%) | 0.050 | ||
Yes | 37 (15.5) | 11 (8.3) | |
No | 202 (84.5) | 121 (91.7) | |
Crossing the midline (%) | < 0.001 |
||
Yes | 28 (11.7) | 0 (0.0) | |
No | 211 (88.3) | 132 (100.0) |